Journal
ONCOTARGET
Volume 7, Issue 3, Pages 2297-2312Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.6223
Keywords
MEF2; transcription factor; cancer; gene regulation; developmental biology
Categories
Funding
- CIHR Vanier Canada Graduate Scholarship
- Scriver MD/PhD Scholarship
- University of British Columbia Four Year Fellowship
Ask authors/readers for more resources
The MEF2 transcription factors have roles in muscle, cardiac, skeletal, vascular, neural, blood and immune system cell development through their effects on cell differentiation, proliferation, apoptosis, migration, shape and metabolism. Altered MEF2 activity plays a role in human diseases and has recently been implicated in the development of several cancer types. In particular, MEF2B, the most divergent and least studied protein of the MEF2 family, has a role unique from its paralogs in non-Hodgkin lymphomas. The use of genome-scale technologies has enabled comprehensive MEF2 target gene sets to be identified, contributing to our understanding of MEF2 proteins as nodes in complex regulatory networks. This review surveys the molecular interactions of MEF2 proteins and their effects on cellular and organismal phenotypes. We include a discussion of the emerging roles of MEF2 proteins as oncogenes and tumor suppressors of cancer. Throughout this article we highlight similarities and differences between the MEF2 family proteins, including a focus on functions of MEF2B.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available